KOL Pulse — Conference Intelligence

ELCC 2026

AI-native conference intelligence from the European Lung Cancer Congress. Copenhagen, Denmark · March 25–28, 2026

497
Tweets Analyzed
75+
KOLs Tracked
15
New Trials
26+
Countries

ELCC 2026 — New Clinical Trial Data

AI-generated trial profiles with KOL sentiment analysis, slide OCR, and engagement data. Sorted by total impressions.

TOP Study
Osimertinib + Chemotherapy
1L EGFRm + TP53-mutant advanced NSCLC
29 tweets 97.6K impressions
View Profile →
i-TIMES
ICI Timing Optimization
Advanced NSCLC immunotherapy scheduling
16 tweets 78.3K impressions
View Profile →
NorthStar
Osimertinib + Local Consolidative Therapy
Metastatic EGFRm NSCLC
26 tweets 53.8K impressions
View Profile →
OptiTROP-Lung-03
Sacituzumab-Tirumotecan (Sac-TMT)
EGFRm NSCLC post-TKI
15 tweets 33.3K impressions
View Profile →
3082-CL-0101
Setidegrasib
KRAS G12D-mutant advanced NSCLC
12 tweets 33.1K impressions
View Profile →
PRESERVE-003
Gotistobart
2L+ squamous NSCLC
15 tweets 30.2K impressions
View Profile →
LATIFY
Negative Trial
Ceralasertib + Durvalumab
LA/metastatic NSCLC
9 tweets 20.8K impressions
View Profile →
BL-B01D1
Iza-bren + Serplulimab
Extensive-stage SCLC
10 tweets 20.5K impressions
View Profile →
ADEPPT
Adagrasib
KRAS G12C perioperative NSCLC
13 tweets ~15K impressions
View Profile →
BECOME
Becotarug + Osimertinib
EGFR exon 20 insertion NSCLC
10 tweets 10.0K impressions
View Profile →
NCT05879978
Obrixtamig + Ezabenlimab
DLL3-expressing SCLC/NEC
4 tweets 8.0K impressions
View Profile →
KandleLit-001
Glecirasib
KRAS G12C advanced NSCLC
8 tweets 7.4K impressions
View Profile →
YL202 (BNT326)
BNT326/YL202 HER3 ADC
HER3-expressing NSCLC
6 tweets 6.8K impressions
View Profile →
JS001-SC
Toripalimab Subcutaneous
Advanced NSCLC (SC vs IV)
5 tweets ~4K impressions
View Profile →
ASTEROID
Durvalumab + SBRT
T1-2N0M0 early-stage NSCLC
5 tweets 3.8K impressions
View Profile →

Referenced Trials at ELCC 2026

Existing trials discussed in the context of ELCC presentations. View their full KOL Pulse profiles.

KOL Influence Networks

Interactive D3.js visualizations mapping retweet, quote, and mention relationships across conference KOLs.

Conference-Wide Network
ELCC 2026 Social Influence Network
Interactive D3.js visualization of all ELCC26 KOL interactions — retweets, quotes, and mentions mapped across 75+ authors from 26+ countries.
Explore Network →

Conference Intelligence Assets

Complementary deliverables from the ELCC 2026 coverage cycle.

Methodology

How KOL Pulse generates real-time conference intelligence.

Social Listening

Real-time monitoring of 75+ oncology KOLs across X/Twitter during the conference window, capturing original tweets, retweets, quotes, and thread replies.

Sentiment Analysis

AI-powered classification of every tweet as positive, neutral, or negative, enabling aggregate sentiment tracking per trial and per author.

Slide OCR

Optical character recognition extracts data from conference presentation slides shared as images, capturing PFS, OS, HR, and safety data verbatim.

Engagement Scoring

Composite scoring model combining impressions, likes, retweets, quotes, and replies to identify the highest-impact trial discussions.

Network Analysis

Graph-based mapping of KOL interactions — retweets, quotes, and @mentions — to reveal influence clusters and information flow patterns.

Powered by KOL Pulse — AI-native conference intelligence for oncology.

Conference Intelligence for Your Therapeutic Area

Get real-time KOL tracking, sentiment analysis, and network intelligence for upcoming oncology conferences.

Request a Demo →